About Sanofi
Sanofi is a company based in Paris (France) founded in 1973 by Jean Rene Sautier was acquired by Beximco Pharma in September 2021. It operates as a AI-as-a-Service, Professional Services, and HealthTech. Sanofi has completed 32 acquisitions, including Ablynx, Amunix and BMP Sunstone. Sanofi offers products and services including Vaccines, Medicines, and Consumer Healthcare (Opella). Sanofi operates in a competitive market with competitors including Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
- Headquarter Paris, France
- Founders Jean Rene Sautier
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biotron Limited
-
Annual Revenue
Not available
-
Net Profit
-$210.5 K (USD)90.73as on Jun 30, 2025
-
EBITDA
-$1.35 M (USD)59.91as on Jun 30, 2025
-
Latest Funding Round
Not available
-
Investors
Blackstone
& 8 more
-
Employee Count
Not available
-
Investments & Acquisitions
Ablynx
& 31 more
-
Acquired by
Beximco Pharma
(Sep 14, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Sanofi
Sanofi is a publicly listed company on the ASX with ticker symbol BIT in Australia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Sanofi
Sanofi offers a comprehensive portfolio of products and services, including Vaccines, Medicines, and Consumer Healthcare (Opella).
Vaccines are developed for infectious disease prevention.
Medicines are provided for various therapeutic areas.
Consumer healthcare products are offered for daily wellness.
People of Sanofi
Unlock access to complete
Unlock access to complete
Software Development Team
176 people
Leadership Team
103 people
Head Team
41 people
Global Team
31 people
Finance and Accounting
30 people
Product Management Team
28 people
Operations Team
27 people
Sales and Marketing
24 people
Unlock access to complete
Funding Insights of Sanofi
Investors in Sanofi
Sanofi has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Blackstone, Gates Foundation and Beximco Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified investment management is provided across multiple asset classes.
|
Locked | Locked | Locked | |
|
Provides banking accounts, loans, credit cards, and digital services for individuals and businesses.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Sanofi
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sanofi
Sanofi has strategically engaged in corporate development activities, having acquired 32 companies. Notable acquisitions include Ablynx, Amunix and BMP Sunstone.
Investment portfolio details for Sanofi
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Microglia-focused therapeutics for neurodegenerative diseases are developed.
|
Locked | Locked | 2020 | Locked | |
|
Prescription drugs are distributed across China by the corporation.
|
Locked | Locked | 2019 | Locked | |
|
mRNA immunotherapies for cancer are developed using nanoparticle delivery systems.
|
Locked | Locked | 2019 | Locked |
Complete acquisition details for Sanofi
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Sanofi
Detailed financials for Sanofi
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sanofi Comparisons
Peer comparison for Sanofi
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sanofi
Sanofi operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| Locked | Locked | Locked |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| Locked | Locked | Locked |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| Locked | Locked | Locked |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| Locked | Locked | Locked |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| Locked | Locked | Locked |
Developer of drugs for the treatment of multiple disorders
|
Detailed competitors of Sanofi
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sanofi
Complete news archive for Sanofi
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanofi
Sanofi was founded in 1973 and raised its 1st funding round 36 years after it was founded.
Sanofi is headquartered in Paris, France.
Paul Hudson is the current CEO of Sanofi.
Sanofi is established as a biopharmaceutical company focused on research and development, leveraging artificial intelligence to innovate healthcare solutions. The company is engaged in multiple therapeutic areas including immunology, neurology, oncology, rare blood disorders, rare diseases, and vaccines. Operations are supported by advanced technology platforms and clinical trials to develop new treatments. Sanofi is committed to sustainable healthcare access and environmental impact reduction. Partnerships and external innovation are pursued globally across North America, Europe, and China to enhance its offerings. The companys pipeline includes 82 compounds in clinical development and 24 trials in phase 3, targeting improved health outcomes.
Sanofi's top competitors include Merck, Roivant Sciences and AbbVie.
Sanofi offers Vaccines, Medicines, and Consumer Healthcare (Opella).
Yes, Sanofi is publicly traded on ASX under the ticker symbol BIT.
Sanofi has made 32 acquisitions, including Ablynx, Amunix, and BMP Sunstone.
Sanofi has 9 investors. Key investors include Blackstone, Gates Foundation, Beximco Pharma, European Union, and USAGov.
The ticker symbol of Sanofi is BIT on ASX.